Occupational & Public Dose Limits and ALARA Principles

10 CFR Part 20 Occupational Limits: Whole Body & Dosimetric Summation

Title 10 of the Code of Federal Regulations, Part 20 (10 CFR Part 20), establishes legally binding radiation protection standards. Under 10 CFR 20.1201(a)(1)(i), the annual occupational limit for adult radiation workers is a Total Effective Dose Equivalent (TEDE) of:

$$\text{TEDE} = 50\text{ mSv}\quad (5\text{ rem}\text{ or }5000\text{ mrem})$$

per calendar year. TEDE sums external deep-dose and internal committed stochastic radiation exposures:

$$\text{TEDE} = \text{DDE} + \text{CEDE}$$

where:

• Deep-Dose Equivalent (DDE): Applies to external whole-body radiation exposure, measured at a tissue depth of $1\text{ cm}$ ($1000\text{ mg/cm}^2$).
• Committed Effective Dose Equivalent (CEDE): Quantifies stochastic risk from internal intakes of radioactive material over a 50-year commitment period:

$$\text{CEDE} = \sum_{T} w_T H_{50,T}$$

where $w_T$ is the tissue weighting factor (10 CFR 20.1003, derived from ICRP Publication 26/60) and $H_{50,T}$ is the committed equivalent dose delivered to organ or tissue $T$ over 50 years.

Since the 2008 amendment of the TEDE definition in 10 CFR 20.1003, licensees may use the effective dose equivalent (EDE) for external exposure in place of the DDE when it is determined by an acceptable method. For staff wearing lead aprons, Regulatory Guide 8.40 describes two-dosimeter methods such as the NCRP Report 122 formula $H_E = 0.5\,H_W + 0.025\,H_N$ and the Webster formula $H_E = 1.5\,H_W + 0.04\,H_N$, where $H_W$ is the under-apron waist reading and $H_N$ the over-apron collar reading.

Organ-Specific Limits: Lens, Extremities, and Total Organ Dose Equivalent

To prevent deterministic tissue reactions, 10 CFR 20.1201 codifies specific annual non-stochastic occupational limits:

• Lens Dose Equivalent (LDE):

$$\text{LDE} = 150\text{ mSv}\quad (15\text{ rem})\quad\text{per calendar year}$$

evaluated at a tissue depth of $0.3\text{ cm}$ ($300\text{ mg/cm}^2$). This limit prevents radiation-induced cataractogenesis. Candidates must note an essential regulatory divergence: ICRP Publication 118 (2012) recommended reducing the occupational lens limit to $20\text{ mSv/yr}$ (averaged over 5 years, no year $>50\text{ mSv}$) based on subcapsular cataract thresholds at $\approx 0.5\text{ Gy}$. While adopted internationally, the US NRC standard in 10 CFR 20.1201 remains legally codified at $150\text{ mSv/yr}$.

• Shallow-Dose Equivalent (SDE):

$$\text{SDE} = 500\text{ mSv}\quad (50\text{ rem})\quad\text{per calendar year}$$

applicable to the skin of the whole body or skin of an extremity (hands, forearms, feet, ankles), evaluated at a tissue depth of $0.007\text{ cm}$ ($7\text{ mg/cm}^2$) averaged over $10\text{ cm}^2$ of the most highly irradiated area.

• Total Organ Dose Equivalent (TODE):

$$\text{TODE} = 500\text{ mSv}\quad (50\text{ rem})\quad\text{per calendar year}$$

to any individual organ or tissue other than the lens of the eye (10 CFR 20.1201(a)(1)(ii)). TODE prevents deterministic organ dysfunction and is defined as:

$$\text{TODE} = \text{DDE} + \text{CDE}$$

where $\text{CDE}$ ($H_{50,T}$) is the committed dose equivalent to the specific organ over 50 years. In medical health physics, TODE commonly governs personnel handling unsealed $^{131}\text{I}$, where thyroid dose limits may be approached before the TEDE whole-body limit.

• Minors (< 18 yrs): Annual limits are exactly 10% of adult limits (10 CFR 20.1207): $\text{TEDE} = 5\text{ mSv}$, $\text{LDE} = 15\text{ mSv}$, and $\text{SDE/TODE} = 50\text{ mSv}$.

Embryo/Fetus Dose Limits & Declared Pregnant Worker Management

Protection of the embryo/fetus of an occupationally exposed worker is governed by 10 CFR 20.1208:

• Voluntary Written Declaration: Declaration is strictly voluntary. An employer cannot compel a worker to declare pregnancy or alter job assignments without consent. The declaration must be in writing, dated, and state the estimated month and year of conception. The worker retains the unconditional right to revoke the declaration in writing at any time without explanation.
• Dose Limit: The dose equivalent to the embryo/fetus during the entire gestation period, due to occupational exposure of a declared pregnant woman, shall not exceed:

$$\text{Embryo/Fetus Limit} = 5\text{ mSv}\quad (0.5\text{ rem}\text{ or }500\text{ mrem})$$

• Monthly Dose Uniformity: Under 10 CFR 20.1208(b) the licensee must make efforts to avoid substantial variation above a uniform monthly exposure rate. NCRP Report 116 recommends a monthly equivalent-dose limit of:

$$\text{Monthly Rate} \le 0.5\text{ mSv/month}\quad (50\text{ mrem/month})$$

• Remedial Provision (10 CFR 20.1208(d)): If the embryo/fetus dose has reached or exceeded $5\text{ mSv}$ (or is within $0.5\text{ mSv}$ of this limit) by the declaration date, the licensee is compliant if additional dose during the remainder of pregnancy does not exceed:

$$\text{Additional Allowance} = 0.5\text{ mSv}\quad (50\text{ mrem})$$

• Dosimetric Monitoring: A dedicated fetal badge must be worn at the waist under any lead protective garments to measure dose to the conceptus.

Public Dose Limits & Unrestricted Area Dose Rate Constraints

Under 10 CFR 20.1301, licensed operations must satisfy two independent public radiation protection criteria:

1. Annual TEDE Limit: Total effective dose equivalent to individual members of the public shall not exceed:

$$\text{Public TEDE} = 1\text{ mSv}\quad (0.1\text{ rem}\text{ or }100\text{ mrem})\quad\text{per calendar year}$$

Excludes natural background radiation, medical administrations to the individual, voluntary medical research, and licensed sanitary sewer disposals. 2. Unrestricted Area Hourly Rate Limit: The external radiation dose rate in any unrestricted area shall not exceed:

$$\text{Hourly Rate} \le 0.02\text{ mSv}\quad (2\text{ mrem})\quad\text{in any one hour}$$

This hourly ceiling prevents localized radiation hot spots in corridors, waiting rooms, and perimeter areas.

Medical Patient Release (10 CFR 35.75)

A major statutory exception permits releasing patients administered radiopharmaceuticals (e.g., $^{131}\text{I}$) or permanent brachytherapy implants (e.g., $^{125}\text{I}$ seeds) if the TEDE to any other individual from exposure to the patient is not likely to exceed:

$$\text{Patient Release Threshold} = 5\text{ mSv}\quad (0.5\text{ rem})$$

If the dose to any individual is likely to exceed $1\text{ mSv}$ ($0.1\text{ rem}$), the licensee must provide written safety instructions to maintain family and public doses ALARA, including specific breastfeeding cessation guidance.

Operational ALARA Programs, Action Levels, and RSO Investigations

Under 10 CFR 20.1101, licensees must maintain an active ALARA program. Regulatory Guide 8.10 states the ALARA operating philosophy; in practice, RSOs screen dosimetry reports with the two-tier investigational levels of the NRC's long-standing model ALARA program (historically Regulatory Guide 10.8, Appendix G), which many medical licensees still adopt:

• Investigational Level I (10% of the annual limit, prorated per quarter):
  • $\text{TEDE} = 1.25\text{ mSv}$ ($125\text{ mrem}$); $\text{LDE} = 3.75\text{ mSv}$ ($375\text{ mrem}$); $\text{SDE/TODE} = 12.5\text{ mSv}$ ($1250\text{ mrem}$).
  • Action: RSO reviews dosimeter reading against worker history and files documentation. No formal operational change required unless an adverse trend appears.
• Investigational Level II (30% of the annual limit, prorated per quarter):
  • $\text{TEDE} = 3.75\text{ mSv}$ ($375\text{ mrem}$); $\text{LDE} = 11.25\text{ mSv}$ ($1125\text{ mrem}$); $\text{SDE/TODE} = 37.5\text{ mSv}$ ($3750\text{ mrem}$).
  • Action: RSO must conduct a formal written root-cause investigation, interview the worker, inspect shielding apparatus and techniques, recommend corrective actions, and submit findings to the Radiation Safety Committee (RSC).
• Annual Program Review (10 CFR 20.1101(c)): Licensees must review radiation protection program content and implementation at least annually.

Summary of 10 CFR Part 20 Limits & Worked Clinical Calculation

Worked Clinical Calculation: Dual-Limit Compliance Evaluation

Scenario: A radiopharmacist receives an external deep-dose equivalent of $\text{DDE} = 16\text{ mSv}$ during hot-lab compounding. Routine thyroid bioassay after handling unsealed $^{131}\text{I}$ detects an internal uptake resulting in an estimated committed dose equivalent to the thyroid of $\text{CDE}_{\text{thyroid}} = 380\text{ mSv}$. Given a thyroid tissue weighting factor of $w_{\text{thyroid}} = 0.03$:

1. Calculate Committed Effective Dose Equivalent (CEDE):

$$\text{CEDE} = w_{\text{thyroid}} \times \text{CDE}_{\text{thyroid}} = 0.03 \times 380\text{ mSv} = 11.4\text{ mSv}$$

1. Calculate Total Effective Dose Equivalent (TEDE):

$$\text{TEDE} = \text{DDE} + \text{CEDE} = 16\text{ mSv} + 11.4\text{ mSv} = 27.4\text{ mSv}$$

TEDE Compliance: $27.4\text{ mSv} \le 50\text{ mSv}$ (Compliant with annual whole-body occupational limit). 3. Calculate Total Organ Dose Equivalent (TODE) to the thyroid:

$$\text{TODE}_{\text{thyroid}} = \text{DDE} + \text{CDE}_{\text{thyroid}} = 16\text{ mSv} + 380\text{ mSv} = 396\text{ mSv}$$

TODE Compliance: $396\text{ mSv} \le 500\text{ mSv}$ (Compliant with annual non-stochastic organ limit). Operational Conclusion: Both limits are met. However, even if the $16\text{ mSv}$ external dose were spread evenly over four quarters ($4\text{ mSv}$ each), every quarter would exceed the Level II investigational level of $3.75\text{ mSv}$, so the RSO must investigate and report corrective actions to the RSC.